LLY compared with PHIO: revenue, margins and what each company keeps, and the suppliers and customers both name

LLYELI Lilly & Co

Mkt capRevenueRevenue

PHIOPhio Pharmaceuticals Corp.

Mkt capRevenueRevenue

Compare

LLYELI Lilly & Co

PHIOPhio Pharmaceuticals Corp.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

LLYELI Lilly & Co

1,421.96▲+0.89%

Mkt cap$1.3TRevenue$24.4BQ3 FY26Revenue$65.2BFY25

PHIOPhio Pharmaceuticals Corp.

0.86▼−4.55%

Regular sessionNov 4 '26

Mkt cap$10.5MRevenue$6,000Q4 FY23Revenue—

Compare

Regular sessionNov 4 '26

LLYELI Lilly & Co

PHIOPhio Pharmaceuticals Corp.

1,421.96▲+0.89%

Price

0.86▼−4.55%

$1.3T

Mkt cap

$10.5M

Q3 FY26$24.4B

Revenue

$6,000Q4 FY23

FY25$65.2B

Revenue

—

LLY1,421.96▲+0.89%vsPHIO0.86▼−4.55%Regular sessionNov 4 '26

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

PHIO: latest quarter is a loss; flow not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only LLY 29

MCKMcKessoncustomer

CAHCardinal Healthcustomer

VEEVVeeva Systemssupplier

UTHRUnited Therapeuticscustomer

25 more · LLY chain ›

Shared 0

No shared counterparties.

Only PHIO 1

—Advanced RNA Technologiesunlistedsupplier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

Price

rebased to 0%

LLY, solidPHIO, dashed